Skip to content
ADMETatlas
peptide evidence atlas
Home
About
Home

Browse

PeptidesProductsEvidenceContext signalsDescriptors

Developability

ProfileComparator

Resources

ManualExplanationsStatisticsDownloadLicenseAbout
  1. Home
  2. Peptides
  3. Daptomycin
Peptide·plain sequence-like

Daptomycin

ATLPC0006669

Routes
Compare in workbenchDownload releaseAPI JSON
On this page
  • 01 Sequence & molecular identity
  • 02 Physicochemical profile
  • 03 Exposure / Absorption
  • 04 Distribution / Barrier
  • 05 Excretion / Persistence
  • 06 Evidence landscape
  • 07 Product context
  • 08 Identity & reference map
  • 09 Data access & reproducibility
Coveragecounts only · not riskATLPC0006669
  • Measurements
    69
  • Endpoints
    5
  • Domains
    3/5
  • Products
    1
  • No matrix stability evidence
  • 15 clearance measurements
  • Product-level review pending
  • No sequence liability cues
Jump to domain

Open the matching evidence section below

All evidence index · 69
Exposure / Absorption
32 measurements
Distribution / Barrier
22 measurements
Metabolic & Proteolytic Stability
No evidence
Excretion / Persistence
15 measurements
Toxicity / Safety
No evidence
01

Sequence & molecular identity

1 forms

Reviewed sequence, peptidoform forms, chemical representation, 3D references, and covalent topology used to interpret this peptide identity.

No reviewed sequence representation available

This peptide currently has identity-level evidence, but no reviewed sequence, HELM, or SMILES representation for residue-level interpretation.

Structure & chemistry

·
Chemical representationnone
Representation class

How the current release can interpret this identity chemically.

plain sequence-like
Parent-residue sequence

Residue string used for positional interpretation when available.

Not available
HELM

Polymer notation for modified peptide representation when available.

Not available
SMILES

Chemical graph string used for atom-level 2D depiction when available.

Not available
No atom-level graph

A reviewed SMILES is required before a 2D molecular depiction can be shown. Sequence and HELM remain useful for identity interpretation, but they do not replace a chemical graph.

3D structure referencesnone attached
3D structure not available

A 3D structure isn't available for this peptide in the current release. Chemistry and topology fields remain available when represented by sequence, HELM, or SMILES.

Covalent topology & modificationsnone
Exact topology not established

No reviewed form-level topology or residue-level connection annotation is attached to this peptide in the current release. This is not evidence that every molecular form is linear or unmodified.

02

Physicochemical profile

6 descriptors

Computed sequence-derived descriptors and any measured physicochemical evidence such as lipophilicity. Computed values are interpretation aids, not experimental ADMET measurements.

Physicochemical descriptors unavailable

These descriptors require a standard parent-residue sequence. The module remains visible so modified or unresolved identities are not forced into unreliable computed values.

Computed developability descriptors

Deterministic descriptors computed from the reviewed sequence or chemical structure (RDKit), each anchored to a literature method. These are computed estimates for developability interpretation — not experimental measurements — and are validated against independent reference implementations.

Structure-derived (developability)

Computed from the representative peptidoform's chemical structure. Rule-of-5 / beyond-Ro5 framing per Lipinski/Doak.

Topological polar surface area
702.0 Ų
Computed logP (Crippen)
-5.62

Computed logP — distinct from the measured logD endpoint.

Hydrogen-bond donors
22
Hydrogen-bond acceptors
24
Rotatable bonds
35
Rule-of-5 / beyond-Ro5 flags
Beyond bRo5

3 Ro5 violations · MW 1,620.69 Da

03

Exposure / Absorption

32 records

What evidence describes systemic exposure or absorption?

Evidence records
32
Complete canonical measurements and observations attached to this domain.
Endpoint scope
2
Formal ADMET endpoints represented for this peptide.
Matched-context in preview
0
Quantitative results that may be analysed only with scientifically compatible records.
Reported results in preview
9
Qualitative, narrative, or review-first results interpreted in their source context.
Endpoints in scopeAUCCmax
Loading 32 Exposure / Absorption records…
04

Distribution / Barrier

22 records

What is known about distribution, binding, permeability, or barrier crossing?

Evidence records
22
Complete canonical measurements and observations attached to this domain.
Endpoint scope
2
Formal ADMET endpoints represented for this peptide.
Matched-context in preview
1
Quantitative results that may be analysed only with scientifically compatible records.
Reported results in preview
6
Qualitative, narrative, or review-first results interpreted in their source context.
Endpoints in scopePlasma protein bindingVd
Loading 22 Distribution / Barrier records…
Barrier and permeability assay context

PAMPA, Caco-2, MDCK/RRCK, and BBB findings are assay/model contexts under Distribution / Barrier. They should not be read as interchangeable measurements.

PAMPA
0

artificial membrane

Caco-2
0

cell monolayer

MDCK
0

cell monolayer

RRCK
0

cell monolayer

BBB
0

barrier evidence

05

Excretion / Persistence

15 records

What evidence describes clearance or persistence?

Evidence records
15
Complete canonical measurements and observations attached to this domain.
Endpoint scope
1
Formal ADMET endpoints represented for this peptide.
Matched-context in preview
0
Quantitative results that may be analysed only with scientifically compatible records.
Reported results in preview
4
Qualitative, narrative, or review-first results interpreted in their source context.
Endpoints in scopeClearance
Loading 15 Excretion / Persistence records…
06

Evidence landscape

69 records

Cross-domain evidence distribution and measurement-level detail. 20 of 69 evidence records are included in the profile preview; the full index is loaded below.

Loading 69 measurements…
07

Product context

1 products

Product-level route, label, and clinical context that frames peptide-level evidence. A peptide-level summary only; product pages keep the full drilldown.

·
Summary1 linked product
Linked products
1
Label context
None
Clinical trials
25
Safety label cues
None
Linked products1 shown

Daptomycin

Peptide-product match
Reviewed peptide match
Route / product class
Intravenous (Intravenous) Injection
Clinical context
25 trial records · 15 exact intervention matches · 7 with results · latest 2026-01-29
Label safety context
No label safety cue linked
View product
08

Identity & reference map

69 sources

Reference-level support for checking reported names, sequence notation, and peptide identity agreement.

·
Summary3 reference groups
Identity type
identity record
Reported notation
1
Reference groups
3
Measurements
69
ATL peptide ID
ATLPC0006669
Identity concordance
Identity concordance
Exact reported notation

Reported sequence string matches the current peptide notation.

0 / 69
Parent-residue compatible

Reported notation differs, but resolves to the same parent-residue display.

0 / 69
Different notation

Reported notation does not resolve to the current display sequence.

1 / 69
Source sequence not captured

No source-specific sequence was captured for comparison; this is not interpreted as agreement or disagreement.

68 / 69
Reported sequence notation
Different1 reference
Dec-WnDTGXDaDGsXX
Current identity
No sequence representation
Reported names
No distinct human-readable aliases are exposed.
Reference map3 reference groups
Reference map

Grouped by reference link, with endpoint scope and reported identity kept visible.

ReferenceSupportsReported identityRecords
Reference
Open
DistributionExposurePersistence
Area Under Curve, Clearance, Max Concentration, Volume Of Distribution
No reported alias
67 identity
18 evidence
Source record
Open
Distribution
Plasma Protein Binding
No reported alias
Dec-WnDTGXDaDGsXXdifferent
1 identity
1 evidence
Reference
Open
Distribution
Plasma Protein Binding
No reported alias
1 identity
1 evidence
09

Data access & reproducibility

Stable record access, analysis-ready files, and scripted retrieval for reproducing this profile view.

·
Record scopePublic release
ATL peptide ID
ATLPC0006669
Identity type
identity record
ADMET endpoints
5
Evidence records
69
Reference groups
3
Release view
Public release
Data access

Structured peptide profile

JSON

Peptide-specific profile used by this page, including identity and evidence context.

Open JSON

Peptide catalogue

TSV

Complete frozen peptide table. Filter the ATL peptide ID column locally to isolate this record.

Download catalogue

Measurement catalogue

TSV

Complete frozen measurement table. Join or filter by ATL peptide ID for peptide-level analysis.

Download measurements
Programmatic access

The request returns the same structured peptide record used by this profile. The tabular downloads are complete frozen release tables and should be filtered locally by ATL peptide ID.

Open endpoint
GET /api/v1/peptides/ATLPC0006669
open
curl -sS 'https://admetatlas.scbdd.com/api/v1/peptides/ATLPC0006669' \
  -H 'accept: application/json' \
  -H 'X-Visibility: public_release'
ADMETatlas
peptide evidence atlas

ADMETatlas is an open, curated atlas of ADMET evidence for therapeutic peptides — spanning developability, membrane permeability and blood–brain-barrier transport, immune-recognition context, and approved-product context. Every measurement stays linked to its original source, with stable identifiers and transparent curation, so results can be traced, cited, and reproduced.

Browse
PeptidesProductsEvidenceContext signalsDescriptors
Resource
DevelopabilityComparatorManualExplanationsStatisticsDownloadAbout
Stack
  • RDKit
  • Mol*
  • Python
  • FastAPI
  • PostgreSQL
  • Next.js
  • React
  • TypeScript
  • Tailwind CSS
  • Apache ECharts
© 2026 ADMETatlas, an academic peptide ADMET evidence atlas.